Lördag 19 September | 23:53:10 Europe / Stockholm
Est. tid*
2026-08-13 - Kvartalsrapport 2026-Q2
2026-05-15 - X-dag bonusutdelning CRBN 0.36
2026-05-15 - X-dag ordinarie utdelning CRBN 0.64 EUR
2026-05-13 - Årsstämma
2026-02-26 - Bokslutskommuniké 2025
2025-07-31 - Kvartalsrapport 2025-Q2
2025-05-16 - X-dag ordinarie utdelning CRBN 0.64 EUR
2025-05-14 - Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-08-08 - Kvartalsrapport 2024-Q2
2024-05-17 - X-dag ordinarie utdelning CRBN 0.61 EUR
2024-05-15 - Årsstämma
2024-05-02 - X-dag bonusutdelning CRBN 0.1
2024-03-01 - Bokslutskommuniké 2023
2023-08-10 - Kvartalsrapport 2023-Q2
2023-05-19 - X-dag ordinarie utdelning CRBN 0.56 EUR
2023-05-17 - Årsstämma
2023-03-03 - Bokslutskommuniké 2022
2022-08-10 - Kvartalsrapport 2022-Q2
2022-07-05 - Extra Bolagsstämma
2022-05-20 - X-dag ordinarie utdelning CRBN 0.56 EUR
2022-05-18 - Årsstämma
2022-02-25 - Bokslutskommuniké 2021
2021-10-27 - Kvartalsrapport 2021-Q3
2021-07-20 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning CRBN 0.56 EUR
2021-05-19 - Årsstämma
2021-04-30 - Kvartalsrapport 2021-Q1
2021-03-05 - Bokslutskommuniké 2020
2020-10-12 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning CRBN 0.56 EUR
2020-06-29 - Årsstämma
2020-04-30 - Kvartalsrapport 2020-Q1
2020-01-13 - Bokslutskommuniké 2019
2019-11-01 - Kvartalsrapport 2019-Q3
2019-08-07 - Kvartalsrapport 2019-Q2
2019-08-05 - Extra Bolagsstämma
2019-04-26 - Kvartalsrapport 2019-Q1
LandNederländerna
SektorMaterial
IndustriPlast, kemikalier & fetter
Corbion är verksamt inom livsmedelsindustrin. Bolaget är specialiserat inom utveckling av mjölksyra och emulgeringsmedel. Utöver produceras även mineraler och vitaminer för olika hälsotillskott. En sidoverksamhet återfinn i utveckling av biobaserade kemikalier för hantering av biomaterial, plast och restprodukter. Verksamhet innehas på global nivå, med störst affärsverksamhet inom den europeiska marknaden.

All ägardata du vill ha finns i Holdings!

Correction: Corbion announces quarterly sales of € 293.7m and Adjusted EBITDA of € 37.8m; maintains full-year outlook

2026-04-22 08:40:34

Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for Q1 2026 ending 31 March.

Key results Q1 2026:

• Organic sales growth: -4.1%% 
     ◦ Volume/mix: -2.6% 
     ◦ Price: -1.5% 
• Sales: € 293.7 million 
• Adjusted EBITDA: € 37.8 million 
• Operating profit: € 14.7 million 

Outlook FY 2026:

  • FY 2026 outlook affirmed

€ millionQ1 2026Q1 2025 Total growthOrganic growth
Sales293.7329.7 -10.9%-4.1%
Adjusted EBITDA37.854.4 -30.5%-19.7%
Adjusted EBITDA margin (%)12.9%16.5%   
Operating profit14.734.0 -56.8%-50.0%


Commenting on today’s results, Olivier Rigaud, CEO, stated: “In line with earlier guidance, Corbion experienced negative growth in both sales and earnings versus Q1 2025. This was due in part to a high comparable from Q1 2025 for Functional Ingredients & Solutions and partly due to phasing– as expected– in the Nutrition business in 2026. We expect sales in Health & Nutrition to strengthen from Q2 onwards and more than compensate for Q1. We anticipate a return to positive volume/mix growth in the remaining quarters of the year.

Adjusted EBITDA margins for the company came down -360 bps mainly due to mix effects and low operational leverage driven by the temporarily low sales level in Health & Nutrition.

Macroeconomic and geopolitical uncertainty, particularly the conflict in the Middle East are creating price and supply-chain challenges that our teams are tackling head-on. To support our full-year Adjusted EBITDA margin guidance, we have immediately implemented a cost reduction program starting to deliver savings as of Q2.

We remain on track to deliver our 2026 guidance on all forecasted metrics, including sales growth, Adjusted EBITDA margin, and Free Cash Flow.”